Long-term mavacamten exposure reduces force and sarcomere density in a hiPSC model of hypertrophic cardiomyopathy
Marianna Langione, Lucrezia Giammarino, Roberto Semeraro, Beatrice Scellini, Sonette Steczina, Valentina Spinelli, Elema Martelli, Irma Della Corte, Camilla Olianti, Alberto Magi, Leonardo Sacconi, Elisabetta Cerbai, Michael Regnier, Iacopo Olivotto, Chiara Tesi, , Josè Manuel Pioner
This study examines the long-term effects of mavacamten on sarcomere structure and function in hiPSC-derived cardiomyocytes from HCM patients, finding a biphasic reduction in force and structural remodeling.
Cardiovascular Research · Jul 13, 2026Peer-reviewedPhysiology